CSPC Pharmaceutical Group (STU:CVG) Cash-to-Debt : 18.52 (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is CSPC Pharmaceutical Group Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. CSPC Pharmaceutical Group's cash to debt ratio for the quarter that ended in Dec. 2023 was 18.52.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, CSPC Pharmaceutical Group could pay off its debt using the cash in hand for the quarter that ended in Dec. 2023.

The historical rank and industry rank for CSPC Pharmaceutical Group's Cash-to-Debt or its related term are showing as below:

STU:CVG' s Cash-to-Debt Range Over the Past 10 Years
Min: 1.2 Med: 21.17 Max: 114.06
Current: 18.52

During the past 13 years, CSPC Pharmaceutical Group's highest Cash to Debt Ratio was 114.06. The lowest was 1.20. And the median was 21.17.

STU:CVG's Cash-to-Debt is ranked better than
81.87% of 1048 companies
in the Drug Manufacturers industry
Industry Median: 0.935 vs STU:CVG: 18.52

CSPC Pharmaceutical Group Cash-to-Debt Historical Data

The historical data trend for CSPC Pharmaceutical Group's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

CSPC Pharmaceutical Group Cash-to-Debt Chart

CSPC Pharmaceutical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

31.77

27.88

114.07

23.81

18.52

CSPC Pharmaceutical Group Quarterly Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cash-to-Debt	Get a 7-Day Free Trial															23.81	N/A	29.12	N/A	18.52

Competitive Comparison of CSPC Pharmaceutical Group's Cash-to-Debt

For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CSPC Pharmaceutical Group's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where CSPC Pharmaceutical Group's Cash-to-Debt falls into.

CSPC Pharmaceutical Group Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

CSPC Pharmaceutical Group's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1681.412	/	(77.037	+	13.749)
	=	18.52

CSPC Pharmaceutical Group's Cash to Debt Ratio for the quarter that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	1681.412	/	(77.037	+	13.749)
	=	18.52

CSPC Pharmaceutical Group (STU:CVG) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

CSPC Pharmaceutical Group Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

CSPC Pharmaceutical Group (STU:CVG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (STU:CVG) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

CSPCY:USA CHJTF:USA 01093:Hong Kong CVG:Germany

Address

No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035

Website

https://www.cspc.com.hk

CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C, antibiotics, and a caffeine series.